|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Restructuring costs | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income, net | |||
| Net loss | |||
| Net loss attributable to redeemable convertible noncontrolling interests | |||
| Other comprehensive loss: | |||
| Currency translation adjustments | |||
| Unrealized gain (loss) on investments | |||
| Total comprehensive loss | |||
| Comprehensive loss attributable to redeemable convertible noncontrolling interests | |||
| Weighted-average shares outstanding, basic (in shares) | |||
| Weighted-average shares outstanding, diluted (in shares) | |||
| Net loss per share, basic (in dollars per share) | |||
| Net loss per share, diluted (in dollars per share) |
Loading...
